Free Trial

AngioDynamics (ANGO) Earnings Date, Estimates & Call Transcripts

AngioDynamics logo
$12.43 -0.34 (-2.66%)
Closing price 01/17/2025 04:00 PM Eastern
Extended Trading
$12.54 +0.12 (+0.93%)
As of 08:41 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AngioDynamics Latest Earnings Summary

Upcoming Q3
Earnings Date
Apr. 3Before Market OpensEstimated
Actual EPS
(Jan. 8)
-$0.04 Beat By $0.07
Consensus EPS
(Jan. 8)
-$0.11

AngioDynamics issued Q2 2025 earnings on January 8, 2025, reporting an EPS of -$0.04, which topped the consensus estimate of -$0.11 by $0.07. Quarterly revenue fell .1% year-over-year to $72.90 million, above analyst estimates of $70.93 million. With a trailing EPS of -$5.63, AngioDynamics' earnings are expected to grow next year, from ($0.37) to ($0.25) per share.

ANGO Upcoming Earnings

AngioDynamics' next earnings date is estimated for Thursday, April 3, 2025, based off prior year's reporting schedules.

Get AngioDynamics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AngioDynamics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ANGO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ANGO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

AngioDynamics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20252-$0.15-$0.13-$0.14 
Q2 20252-$0.12-$0.10-$0.11 
Q3 20252-$0.11-$0.10-$0.11 
Q4 20252-$0.08-$0.07-$0.08 
FY 20258-$0.46-$0.40-$0.43 
Q1 20261-$0.13-$0.13-$0.13 
Q2 20261-$0.12-$0.12-$0.12 
Q3 20261-$0.03-$0.03-$0.03 
Q4 20261$0.01$0.01$0.01 
FY 20264-$0.27-$0.27-$0.27 
Q1 20271-$0.09-$0.09-$0.09 

AngioDynamics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/3/2025
(Estimated)
-------
1/8/2025Q2 2025-$0.11-$0.04+$0.07-$0.26$70.93M$72.90M
10/3/2024Q1 2025-$0.15-$0.11+$0.04$0.09$67.93M$67.50M
7/16/2024Q4 2024-$0.17-$0.06+$0.11$0.21$70.86M$71.00M
4/4/2024Q3 2024-$0.14-$0.16 -$0.02$4.41$76.71M$75.18M
1/5/2024Q2 2024-$0.09-$0.05+$0.04$0.62$81.65M$79.07M
10/4/2023Q1 2024-$0.13-$0.12+$0.01-$1.39$77.70M$78.70M
7/12/2023Q2 2023$0.02$0.02-$0.58$90.73M$91.10M
3/30/2023Q3 2023-$0.01-$0.03 -$0.02$0.18$83.20M$80.70M

AngioDynamics Earnings - Frequently Asked Questions

AngioDynamics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 3rd, 2025 based off last year's report dates. Learn more on ANGO's earnings history.

AngioDynamics updated its FY25 earnings guidance on Wednesday, January, 8th. The company provided earnings per share guidance of ($0.38)-($0.34) for the period, compared to the consensus EPS estimate of ($0.40). The company issued revenue guidance of $282-288 million, compared to the consensus revenue estimate of $283.86 million.

In the previous quarter, AngioDynamics (NASDAQ:ANGO) reported ($0.04) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.11) by $0.07. Learn more on analysts' earnings estimate vs. ANGO's actual earnings.

The conference call for AngioDynamics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for AngioDynamics's latest earnings report can be read online.
Read Transcript

AngioDynamics's earnings report can be found in their filing with the SEC.
View SEC filing

AngioDynamics (NASDAQ:ANGO) has a recorded annual revenue of $303.91 million.

AngioDynamics (NASDAQ:ANGO) has a recorded net income of -$184.35 million. ANGO has generated -$5.63 earnings per share over the last four quarters.

AngioDynamics's earnings are expected to grow from ($0.36) per share to ($0.25) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ANGO) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners